HeartSciences (HSCS) Net Margin (2021 - 2025)

HeartSciences has reported Net Margin for 5 years, with the latest figure at 97269.0% in Q4 2025.

• For the quarter ending Q4 2025, Net Margin changed N/A year-over-year to 97269.0%; the trailing twelve-month figure through Jan 2026 stood at 98078.72% (down 5155990.0% YoY), and the FY2025 full-year result was 203517.79%, down 16771215.0% from the prior year.
• Net Margin for Q4 2025 stood at 97269.0%, up from 108305.63% in the prior quarter.
• The five-year high for Net Margin was 10048.78% in Q3 2021, with the low at 108305.63% in Q3 2025.
• Historically, Net Margin has averaged 53102.13% across 5 years, with a median of 48741.44% in 2022.
• Annual changes were most pronounced in 2022 — Net Margin sank 3912947 bps — and 2024, when it surged 5596161 bps.
• HeartSciences' Net Margin stood at 10048.78% in 2021, then sank by 389 bps to 49178.25% in 2022, then increased by 9 bps to 44830.28% in 2023, then surged by 75 bps to 11182.5% in 2024, then slumped by 770 bps to 97269.0% in 2025.
• The last three Net Margin figures came in at 97269.0% (Q4 2025), 108305.63% (Q3 2025), and 48304.62% (Q2 2025), per Business Quant data.